David Lebowitz analyst BMO

Currently out of the existing stock ratings of David Lebowitz, 196 are a BUY (60.49%), 92 are a HOLD (28.4%), 36 are a SELL (11.11%).

David Lebowitz

Work Performance Price Targets & Ratings Chart

Analyst David Lebowitz, currently employed at BMO, has had 70.98% of price targets met with an average potential upside of 34.6%, reached in 264 days on average. Previously, David Lebowitz worked at CITI.

David Lebowitz has documented 625 price targets and ratings displayed on 34 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ALNY, .

Wall Street Analyst David Lebowitz

Analyst best performing recommendations are on PLRX.
The best stock recommendation documented was for PLRX on 3/4/2025. The price target of $1.5 was fulfilled within 1 day with a profit of $0.15 (11.11%), with a performance score of 111.11.

Average potential price target upside

AKBA ALNY ARQT ASND BPMC GWPH GW Pharmaceuticals plc IONS Ionis Pharmaceuticals IRWD KPTI MGNX RYTM Rhythm Pharmaceuticals SDGR SNDX Syndax Pharmaceuticals ZEAL Zealand Pharma A/S ADR AVRO EPZM MIRM NTLA PLRX NBRV BMRN BBIO COGT Cogent Biosciences PTCT INCY EXEL CLDX CYTK MDGL VKTX ARWR CRNX

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 26-Sep-2023

$4.5

$3.47 (336.89%)

$7.5

2 months 14 days ago
(07-Sep-2026)

15/36 (41.67%)

$3.47 (336.89%)

342

Buy Since 03-Jun-2025

$6

$4.97 (482.52%)

$6

4 months 21 days ago
(30-Jun-2026)

0/5 (0%)

$4.79 (395.87%)

Buy Since 28-Nov-2023

$4

$2.97 (288.35%)

$4

7 months 15 days ago
(06-Apr-2026)

3/7 (42.86%)

$2.62 (189.86%)

578

Buy Since 29-Mar-2022

$4

$2.97 (288.35%)

$2

9 months 16 days ago
(05-Feb-2026)

1/2 (50%)

$2.61 (187.77%)

722

Hold Since 31-May-2023

$4

3 years 5 months 22 days ago
(31-May-2023)

1/12 (8.33%)

$2.96 (284.62%)

784

Show more analysts

Stocks David Lebowitz covered previously. Scores are shown for active stocks only.

BP IMRX

Please expand the browser size to see the chart

Which stock is David Lebowitz most bullish on?

Potential upside of $145.18 has been obtained for ALNY

Which stock is David Lebowitz most reserved on?

Potential downside of -$10.63 has been obtained for EXEL

What Year was the first public recommendation made by David Lebowitz?

On 2016
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?